What is LOPJLB’s current signal on RGNT?

LOPJLB’s latest quantitative signal on Regentis Biomaterials Ltd. (RGNT) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is RGNT in?

Regentis Biomaterials Ltd. (RGNT) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Regentis Biomaterials Ltd. (RGNT) do?

Regentis Biomaterials Ltd. is a regenerative medicine firm dedicated to crafting innovative solutions for tissue repair, ultimately aiming to enhance patients' health and overall quality of life. The company's primary product in development is GelrinC, a novel, cell-free, ready-to-use hydrogel designed to be solidified into an implant within the knee. This implant serves to address painful knee…

Where is Regentis Biomaterials Ltd. based / listed?

Regentis Biomaterials Ltd. is based in IL, listed on AMEX.

Regentis Biomaterials Ltd. (RGNT)

COMPARE

Healthcare · Medical - Instruments & Supplies · AMEX · IL

$1.63-1.21%Close

SELLCRISIS · day 8

[SCORES & PROFILE]

FUND: 0
VALUE: 0
GROWTH: 0
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-

REV YoY-

ROE-

EPS YoY-

ROA-

---

[VALUATION]

P/E TTM-

P/E FWD-

SECTOR PE20.33

INDUSTRY PE44.55

P/B-

P/FCF-

EV/EBITDA-

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO-

ND/EBITDA-

BETA-0.69

Regentis Biomaterials Ltd. (RGNT)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news